ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.165,37
-0,09%
S&P 500
5.302,90
0,11%
US Dollar vs BRL
5,1084
-0,42%
Bitcoin
66.364,06
1,72%
Brent Oil
83,215
0,01%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Capricor Therapeutics Inc (CAPR)

  7. Capricor Therapeutics Inc (CAPR) Notícias

CAPR

Capricor Therapeutics (CAPR)

Capricor Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CAPR
DataHoraFonteTítuloCódigoCompanhia
15/05/202418:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CAPRCapricor Therapeutics Inc
14/05/202410:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CAPRCapricor Therapeutics Inc
13/05/202417:05GlobeNewswire Inc.Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CAPRCapricor Therapeutics Inc
09/05/202410:15GlobeNewswire Inc.Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:CAPRCapricor Therapeutics Inc
08/05/202410:00GlobeNewswire Inc.Capricor Therapeutics to Present at Upcoming Scientific and Medical ConferencesNASDAQ:CAPRCapricor Therapeutics Inc
06/05/202410:00GlobeNewswire Inc.Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13NASDAQ:CAPRCapricor Therapeutics Inc
24/04/202410:00GlobeNewswire Inc.Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular DystrophyNASDAQ:CAPRCapricor Therapeutics Inc
21/03/202409:30GlobeNewswire Inc.Capricor Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:CAPRCapricor Therapeutics Inc
11/03/202409:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CAPRCapricor Therapeutics Inc
29/02/202418:05GlobeNewswire Inc.Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:CAPRCapricor Therapeutics Inc
27/02/202410:30GlobeNewswire Inc.Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular DystrophyNASDAQ:CAPRCapricor Therapeutics Inc
22/02/202410:30GlobeNewswire Inc.Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29NASDAQ:CAPRCapricor Therapeutics Inc
20/02/202410:30GlobeNewswire Inc.Capricor Therapeutics Announces Manufacturing Scale-Up of CAP-1002 Production at New San Diego Facility as it Continues Plans Toward CommercializationNASDAQ:CAPRCapricor Therapeutics Inc
16/02/202419:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CAPRCapricor Therapeutics Inc
24/01/202411:15GlobeNewswire Inc.Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2NASDAQ:CAPRCapricor Therapeutics Inc
04/01/202419:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
17/10/202317:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CAPRCapricor Therapeutics Inc
29/09/202318:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CAPRCapricor Therapeutics Inc
29/09/202318:00Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:CAPRCapricor Therapeutics Inc
06/09/202319:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
15/06/202318:27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CAPRCapricor Therapeutics Inc
13/06/202318:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CAPRCapricor Therapeutics Inc
16/05/202320:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPRCapricor Therapeutics Inc
12/05/202310:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CAPRCapricor Therapeutics Inc
17/04/202318:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CAPRCapricor Therapeutics Inc
17/03/202318:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CAPRCapricor Therapeutics Inc
31/01/202308:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CAPRCapricor Therapeutics Inc
30/11/202212:35TipRanks2 “Strong Buy” Penny Stocks That Could Rally All the Way to $15NASDAQ:CAPRCapricor Therapeutics Inc
12/11/202210:55TipRanksMaxim Group Keeps Their Buy Rating on Capricor Therapeutics (CAPR)NASDAQ:CAPRCapricor Therapeutics Inc
11/11/202208:25TipRanksH.C. Wainwright Sticks to Its Buy Rating for Capricor Therapeutics (CAPR)NASDAQ:CAPRCapricor Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CAPR

Seu Histórico Recente

BIT
P19KG9
BNP Paribas Issuance
GATE
ERGETH
Ergo
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados